UWO FIMS
New Media OLR  
 
   
 
 
NEWS/ DOCUMENTARIES/ ABOUT US
 
Birth control breakthrough
But will it hold mass appeal?
February 14, 2005 
by Liane Cerminara
Photo courtesy of cbc.ca
Intra Vas Device

 A new contraceptive for men is undergoing human clinical trials at the Shepherd Medical Company in Vancouver.

The Intra Vas Device (IVD) is implanted into the vas deferens of the penis to block sperm flow. The 2.5cm hollow silicone plug can later be removed without risk if the man would like to start a family.

Professor Sasha Torres, specialist in sexuality studies at the University of Western Ontario, thinks that any new technology that expands the range of contraceptive possibilities is a plus, but that the focus should be put on a more appealing, non surgical option.

 “It’s not going to be a magic bullet… I don’t think this lets companies…off the hook for developing a pill for men, which theoretically would be a lot easier to do since their reproductive activities are a lot less complicated than women’s’,” she said.           

Photo courtesy of cbc.ca
Dr. Neil Pollock

  Dr. Neil Pollock, co-founder of Shepherd Medical Company, thinks that the IVD can revolutionize birth control and give men a fully reversible and therefore less risky option to a vasectomy.

 Currently, reversing a vasectomy is not only expensive but also reduces the possibility of conception to about 60 per cent.

 The $1000 U.S. IVD is implanted under local anesthetic in a seven minute out patient procedure. A small opening is made in the vas deferens tubes to insert the plugs.

 The nature of the procedure makes men like Clint Terreault uneasy. “Any operation where you can be cutting things open down there and inserting something…is probably not going to appeal to a lot of men,” he said.

The IVD should hit European markets by 2007 and reach North American markets shortly afterwards.

Read more about:
Men's Contraceptives
New Methods of Contraception
Dr. Neil Pollock

Back to Top